Medical News

RSS

World Antimicrobial Awareness Week 2021: An Interview with Pan American Health Organization (PAHO)

For World Antimicrobial Awareness Week (WAAW) 2021, we spoke to Dr. Pilar Ramon Pardo from the Pan American Health Organization.

19 Nov 2021

Comparing effectiveness of virus and patients-centered strategies to reduce COVID-19 mortality

Researchers from Sorbonne Université have been reviewing papers exploring different anti-COVID-19 drugs.

19 Nov 2021

First long-acting injectable HIV treatment appraised and approved by NICE

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc, with Pfizer Inc. and Shionogi Limited as shareholders, is pleased to announce that eligible people living with Human Immunodeficiency Virus (HIV) in England and Wales will soon have routine access to Vocabria (cabotegravir long-acting injection) developed by ViiV Healthcare in combination with Rekambys (rilpivirine long-acting injection), developed by Janssen Sciences Ireland UC (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

19 Nov 2021

Higher arterial stiffness during adolescence linked to increased risk of hypertension, obesity in young adulthood

Researchers from the University of Eastern Finland, the University of Exeter, and the University of Bristol carried out the study using data from one of the world’s most extensive ongoing prospective birth cohort studies – the Avon Longitudinal Study of Parents and Children (ALSPAC).

19 Nov 2021

COVID-19 induced excess mortality

A new study presented a generalized linear mixed model to determine the rate of mortality related to COVID-19 infection in Lombardy, Italy.

19 Nov 2021

Can you take the COVID-19 and Influenza vaccines on the same day?

Scientists have conducted a substudy within a phase 3 UK trial and have reported the safety, immunogenicity, and efficacy of the NVX-CoV2373 COVID-19 vaccine when co-administered with licensed seasonal influenza vaccines.

19 Nov 2021

Predicting the capacity of mammal species to become zoonotic SARS-CoV-2 hosts

Researchers identified a subset of species in which the threat of spillback infection appears the most significant due to location and increased contact with humans in areas with a high prevalence of SARS-CoV-2.

19 Nov 2021

What happens after a campus suicide is a form of prevention, too

Ethan Phillips was 13 years old when he first heard the term "suicide contagion." It's the scientific concept that after one person dies by suicide, others in the community may be at higher risk.

19 Nov 2021

Vaccine-or-test requirements increase work and costs for governments

Amanda Kostroski, a 911 dispatcher in Madison, Wisconsin, leaves her busy job once a week to go to a county health clinic to be tested for covid-19.

19 Nov 2021

The ER charged him $6,500 for six stitches. No wonder his critically ill wife avoided the ER.

Jason and DeeAnn Dean recently relocated to her hometown of Dellrose, Tennessee, where she grew up on a farm. Both in their late 40s, they're trying to start a green dream business that combines organic farming with a health and wellness consulting company.

19 Nov 2021

Viral biomolecular condensation

A review published in PLOS Pathogens deconstructs virus condensation and provides a biochemical background for LLPS.

19 Nov 2021

A covid head-scratcher: Why lice lurk despite physical distancing

The Marker family opened their door on a recent evening to a woman dressed in purple, with a military attitude to cleanliness.

19 Nov 2021

Reducing cell culture contamination with INTEGRA’s versatile pipettes

INTEGRA Biosciences – a leading provider of high quality laboratory equipment – supplies a comprehensive range of liquid handling tools that are ideal for sterile cell biology workflows.

From INTEGRA Biosciences 19 Nov 2021

Population-based risk compensation may have been a driving force in UK's COVID pandemic

The COVID-19 pandemic has irreversibly altered our lives in many ways. However, available COVID vaccines are effective against (symptomatic) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, hospitalizations, and even death. Despite a diminishing protective effect against infection and onward transmission after vaccination, and a slightly diminished effect with the Delta variant compared to the Alpha variant, protection against severe outcomes remains high.

19 Nov 2021

UCLA study shows how COVID vaccination is critical to controlling the pandemic

A study currently available on the medRxiv* preprint server has demonstrated that the incidence and mortality rates of coronavirus disease 2019 (COVID-19) in the US can be significantly reduced at the population level by increasing vaccinate rates from 40% to 80%.

18 Nov 2021

A nasal COVID vaccine using a weakened influenza vector

The authors of a new study, published on the bioRxiv* preprint server, constructed a COVID-19 nasal vaccine candidate by inserting a gene encoding the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2, named CA4-dNS1-nCoV-RBD (dNS1-RBD) in a live attenuated influenza virus (LAIV) vector.

18 Nov 2021

Seroprevalence study in Tamil Nadu shows antibody decline following SARS-CoV-2 infection and vaccination

In the sixth-most populated state of India – Tamil Nadu, three rounds of a district-level serological study were conducted through two COVID waves.

18 Nov 2021

Severe COVID-19 patients have significantly higher NK and T cell frequency

A new study published in the open-access journal Cells aimed to clarify the role of NK and T cell subsets in SARS-CoV-2 infection in hospitalized COVID-19 patients to unravel their potential association with disease severity.

18 Nov 2021

Air filter and floor sampling to detect SARS-CoV-2 RNA in schools

A study recently published on the medRxiv* preprint server observed the presence of SARS-CoV-2 RNA in five schools (96 classrooms) in Davis, California (USA), by collecting weekly surface-swab samples from classroom floors and/or portable high-efficiency particulate air (HEPA) units.

18 Nov 2021

Study involving a rat model offers potential treatment for Alexander disease

Alexander disease is a progressive and rare neurological disorder with no cure or standard course of treatment. But a new study led by researchers at the University of Wisconsin–Madison involving a rat model of the disease offers a potential treatment for the typically fatal condition.

18 Nov 2021